Cannabis Stock Investing Risk Guide: What Every Investor Should Know
Cannabis stocks carry unique risks: regulatory uncertainty, state-by-state market dynamics, banking restrictions, share dilution, and OTC liquidity constraints. Here’s the complete risk guide.
Cannabis Rescheduling Explained: What Schedule III Means for Stocks
The DEA’s proposed cannabis rescheduling from Schedule I to Schedule III would be historic. Here’s what it means for 280E taxes, banking access, institutional investment, and cannabis stock prices.
Top Cannabis Companies to Watch: MSOs vs LPs Explained
GTBIF, CURLF, TCNNF, TLRY, OGI, CGC — a clear breakdown of the top cannabis companies, what each does, MSO vs LP structure, and why the distinction matters for investors.
How to Read a Cannabis Earnings Report
Cannabis earnings reports use different metrics than other sectors. Here’s how to read revenue, adjusted EBITDA, 280E tax impact, free cash flow, and guidance like a pro.
What Is Cannabis Stock Investing? A Beginner’s Guide
New to cannabis stocks? Learn what MSOs and LPs are, how OTC vs. exchange listings work, what Schedule III means, and the core risk factors every investor should understand.
Organigram OGI Tuesday July 21 2026 Midday Analysis Canadian LP Posts 45 Percent YTD Gain as August 11 Earnings and Positive Free Cash Flow Define Pre-Reporting Framework
TL;DR: Organigram Global (OGI) has emerged as the strongest-performing major Canadian licensed producer on a year-to-date basis in 2026, with a 45.34% YTD return that significantly outpaces both sector peers and broad market indices heading into its estimated August 11, 2026 earnings report. Despite trading near the lower end of its 52-week range at approximately […]
Green Thumb Industries GTBIF Tuesday July 21 2026 Midday Analysis Q2 Earnings Date August 4 as Consistent Profitability and 1.2 Billion Revenue Run Rate Define Premium MSO Positioning
TL;DR: Green Thumb Industries (GTBIF) carries the strongest profitability profile in the U.S. cannabis sector heading into its August 4, 2026 Q2 earnings date, with trailing twelve-month revenue of $1.2 billion and diluted EPS of $0.51 that distinguishes it from most multi-state operator peers. At current OTC levels near $7.60, the stock trades at a […]
Cannabis Sector Monday Evening Brief July 20 2026 MSOS Drops 4.39 Percent in Pre-Earnings Consolidation as Q2 Reporting Window Opens July 28
TL;DR: The AdvisorShares Pure US Cannabis ETF (MSOS) closed Monday at $4.36, down 4.39% on below-average volume, as the sector entered pre-earnings consolidation mode. After-hours recovery of +0.66% to $4.39 signals institutional reaccumulation ahead of the Q2 reporting window, which opens with Tilray Brands (TLRY) on July 28 and extends through the first week of […]
TerrAscend Corp TRSSF Monday July 20 2026 Midday Analysis Maryland Ohio and New Jersey State Portfolio Defines Mid-Tier MSO Pre-Earnings Investment Framework
TL;DR: TerrAscend Corp (TRSSF) enters the Q2 2026 earnings reporting window as one of the cannabis sector's most state-diversified mid-tier MSOs, with adult-use dispensary operations across Maryland, Ohio, New Jersey, Michigan, and an established medical presence in Pennsylvania. Maryland's adult-use market is now in its third operational year, Ohio approaches its second anniversary of adult-use […]
Tilray Brands TLRY Monday July 20 2026 Midday Pre-Earnings Analysis Eight Days to Earnings as Stock Tests 52-Week Low Amid Sector Selling Pressure
TL;DR: Tilray Brands (TLRY) enters the final eight trading sessions before its July 28 Q4 FY2026 earnings report at $4.24 — within pennies of its 52-week low of $4.1950 — as the MSOS sector fell 4.4% on Monday. Analyst consensus targets averaging $9.30 imply 120% upside, framing a classic pre-earnings asymmetry: the risk of a […]